Evidence map›Paper›PMID 40025594›Full record

Observational studyItalian journal of pediatrics2025

Evaluation of uNGAL and TIMP-2*IGFBP7 as early biomarkers of Acute Kidney Injury in Caucasian term and preterm neonates: a prospective observational cohort study.

Raffaella Panza, Annalisa Schirinzi, Maria Elisabetta Baldassarre, Rossella Caravita, Riccardo Laterza, Elisa Mascolo, Federica Malerba, Francesca Di Serio, Nicola Laforgia

Abstract readObservational Study
In one paragraph

Observational study in Italian journal of pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Raffaella PanzaNeonatology and Neonatal Intensive Care Unit, Department of Interdisciplinary Medicine, "Aldo Moro" University of Bari, Bari, Italy. raffaella.panza@uniba.it.ORCID http://orcid.org/0000-0003-2489-9500
Annalisa SchirinziClinic Pathology Unit, University Hospital Policlinico, Bari, Italy.
Maria Elisabetta BaldassarreNeonatology and Neonatal Intensive Care Unit, Department of Interdisciplinary Medicine, "Aldo Moro" University of Bari, Bari, Italy.
Rossella CaravitaNeonatology and Neonatal Intensive Care Unit, Department of Interdisciplinary Medicine, "Aldo Moro" University of Bari, Bari, Italy.
Riccardo LaterzaClinic Pathology Unit, University Hospital Policlinico, Bari, Italy.
Elisa MascoloClinic Pathology Unit, University Hospital Policlinico, Bari, Italy.
Federica MalerbaNeonatology and Neonatal Intensive Care Unit, Department of Interdisciplinary Medicine, "Aldo Moro" University of Bari, Bari, Italy.
Francesca Di SerioClinic Pathology Unit, University Hospital Policlinico, Bari, Italy.
Nicola LaforgiaNeonatology and Neonatal Intensive Care Unit, Department of Interdisciplinary Medicine, "Aldo Moro" University of Bari, Bari, Italy.

Funding

Mellin spa Mellin spa
6 · The paper itself

Abstract

backgroundEarly diagnosis of Acute Kidney Injury (AKI) in neonates is a complex challenge. Novel urinary biomarkers such as uNGAL and TIMP-2*IGFBP7 may be helpful for predicting AKI earlier than changes in serum creatinine (sCr) and urinary output (UOP) in the neonatal period. uNGAL is a marker of tubular injury and its concentration rises immediately after AKI, while the proteins TIMP-2 and IGFBP7 jointly participate in the G1 phase cell cycle arrest processes and their tubular expression and urinary excretion increase in response to kidney damage. The aim of this study is to determine urinary concentrations of uNGAL and TIMP-2*IGFBP7 in term and preterm newborns and to evaluate their predictive role of AKI.

methodsForty-two heathy term neonates and twenty-six preterm infants were prospectively recruited at the NICU of Policlinico in Bari, Italy. uNGAL and TIMP-2*IGFBP7 were measured in fresh urinary samples collected via perineal bag either before discharge (term neonates) or over the first week of life (preterm neonates).

resultsIn term neonates median uNGAL and TIMP-2*IGFBP7 concentrations were 41.40 ng/ml (IQR 20.25-74.5) e 0.22 (ng/ml)

conclusionsOur data show that uNGAL could be more useful than TIMP-2*IGFBP7 for early detection of AKI in preterm newborns. Further studies are needed to evaluate the role of both biomarkers during AKI and their relationship with gender, gestational age and birth weight.

Indexed as

Acute Kidney InjuryInsulin-Like Growth Factor Binding ProteinsLipocalin-2Tissue Inhibitor of Metalloproteinase-2BiomarkersCohort StudiesEarly DiagnosisFemaleHumansInfant, NewbornInfant, PrematureItalyMaleProspective StudiesWhite PeopleBiomarkersinsulin-like growth factor binding protein-related protein 1Insulin-Like Growth Factor Binding ProteinsLipocalin-2TIMP2 protein, humanTissue Inhibitor of Metalloproteinase-2Acute kidney injury [Mesh]Biomarkers [Mesh]Neonates [Mesh]NGALPreterm birth [Mesh]TIMP-2*IGFBP7

Identifiers

PMID40025594
PMCPMC11872328

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.